Wolferstans, in the South West has announced that it has selected Axxia DNA from LexisNexis Axxia as its new web-based platform for practice and business management. With the contract concluded just four days after LexisNexis’s acquisition of the PMS supplier, it is understood that the Wolfertsans deal is the first for the new business entity. Axxia DNA will be rolled out to 130 staff with immediate deployment of core functions including accounts, time recording, case management, billing, workflow, KPIs, reporting and contact management.

The major IT project forms part of a wider strategic review headed up by legal business development consultancy, Inpractice. Allan Carton, the Inpractice consultant leading that project explains the rationale for the modernisation:
“Wolferstans decided that their future strategy for growing their business would see them focus on managing client and customer relationships more effectively. To put this into practice they are developing a highly collaborative working environment amongst their people, to streamline the way they work and to be more innovative in how they interact with clients and introducers. Axxia DNA is their chosen solution as it is the most cost-effective way for them of producing the results they want. It provides a range of integrated tools and technologies to enable them to build their whole business around one single database at the core, linked into all the key applications they need; not just to handle the legal work, but to help them run the business better.  

“Business process tools and document management will enable them to develop workflows to manage all aspects of the business from case management to critical HR functions associated with people development. Alongside sophisticated management reporting, these tools will also enable Wolferstans to be proactive in managing internal performance and how they interact and develop their relationships with clients. The new web-based interface is more intuitive and engaging for users to develop and use and the overall solution should prove to be cost-effective to maintain, with potential to continue development, scale up and support this business in the long-term.”


Encouraged by LexisNexis’s takeover of Axxia, the Wolferstans partners moved quickly to conclude the deal. Paul Woods, Senior Partner at Wolferstans comments: “As an existing Axxia user, LexisNexis have satisfied us on their commitment to applying their considerable resources to accelerate development of DNA along the roadmap originally set out by Axxia. That’s reassuring because we want to invest in a system that has enough capability built in to cater for the progressive changes we want to make, to support our ambition. We can also take advantage of other LexisNexis products being more readily accessible from fee earners’ desktops to help them manage their day-to-day interactions with clients more effectively.”


Almost two-thirds of the cost of the deal will be for services (training and development) as compared against hardware and software. The focus is on developing skills and knowledge within the practice to make sure that people develop solutions and use the tools that will become available to them and there is a commitment to introduce continuous improvements in the future.